Svenska Handelsbanken’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,997
Closed -$28.9M 10
2025
Q1
$28.9M Buy
+34,997
New +$29.1M 28.76% 1
2024
Q4
Sell
-37,443
Closed -$33.2M 7
2024
Q3
$33.2M Buy
+37,443
New +$33.7M 16.73% 3
2021
Q1
Sell
-16,100
Closed -$2.72M 22
2020
Q4
$2.72M Buy
+16,100
New +$2.4M 2.01% 21
2020
Q3
Sell
-16,100
Closed -$2.64M 49
2020
Q2
$2.64M Sell
16,100
-5,200
-24% -$798K 2.7% 11
2020
Q1
$2.96M Hold
21,300
3.93% 3
2019
Q4
$2.8M Buy
21,300
+2,300
+12% +$267K 2.93% 11
2019
Q3
$2.13M Buy
19,000
+11,500
+153% +$1.28M 2.54% 19
2019
Q2
$831K Buy
+7,500
New +$883K 0.95% 41
2016
Q3
Sell
-731,499
Closed -$57.6M 106
2016
Q2
$57.6M Buy
+731,499
New +$55.1M 3.53% 11

Other funds holding LLY

Svenska Handelsbanken's LLY Position: Q2 2025 in Review

Svenska Handelsbanken sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 34,997 shares — an estimated $28.9M sold.

Svenska Handelsbanken first reported a position in LLY in Q2 2016 and held it in 9 quarters. The position peaked at $57.6M in Q2 2016. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Svenska Handelsbanken reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Svenska Handelsbanken sold 34,997 Eli Lilly shares in Q2 2025, an estimated $28.9M.
  • Svenska Handelsbanken first reported a position in Eli Lilly in Q2 2016 and held it in 9 quarters.
  • Svenska Handelsbanken's Eli Lilly position peaked at $57.6M in Q2 2016.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Svenska Handelsbanken's 13F filing for Q2 2025, filed 9 Jul 2025.